← All companies
PTIX
Protagenic Therapeutics, Inc.
$0.18
+0.02 +9.58%
Key statistics
from XBRL data in SEC filingsMarket cap
$331K
Revenue (TTM)
$0.00
Net income (TTM)
-$5.16M
EPS (TTM)
$-3.45
P/E ratio
—
Dividend yield
—
Free cash flow
-$4.37M
Cash
$2.21M
Total assets
$4.43M
Gross margin
—
52-week range
$0.13 – $6.20
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Apr 7, 2026
10-Q
Quarter ended 2025-12-31
Mar 9, 2026
8-K
Director or officer change
Mar 3, 2026
8-K
Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Other events
Feb 24, 2026
8-K
Delisting notice or listing-rule failure
Jan 5, 2026
10-Q
Quarter ended 2025-09-30
Nov 26, 2025
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Nov 26, 2025
8-K
Director or officer change
Nov 5, 2025
8-K
Other events
Oct 31, 2025
8-K/A
Sep 17, 2025
8-K/A
Aug 28, 2025
8-K
Delisting notice or listing-rule failure; Changed accountants; Regulation FD disclosure
Aug 22, 2025
8-K
Exit or disposal costs; Director or officer change; Amended charter or bylaws; Other events
Aug 13, 2025
8-K
Regulation FD disclosure
Jul 30, 2025
8-K
Director or officer change
Jul 24, 2025
8-K
Modified rights of security holders
Jun 27, 2025
8-K
Regulation FD disclosure
May 21, 2025
8-K
Entered a material agreement; Unregistered sale of equity
May 20, 2025
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events
May 19, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
8-K
Amended charter or bylaws
May 5, 2025
8-K
Regulation FD disclosure
Apr 29, 2025
8-K
Shareholder vote results
Apr 18, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Director or officer change
Feb 24, 2025
8-K
Shareholder vote results
Feb 24, 2025
8-K
Delisting notice or listing-rule failure
Jan 29, 2025
8-K
Delisting notice or listing-rule failure
Jan 16, 2025
8-K
Entered a material agreement
Jan 10, 2025
8-K
Other events
Dec 3, 2024
8-K
Delisting notice or listing-rule failure
Nov 22, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Regulation FD disclosure; Other events
Nov 5, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Oct 30, 2024
8-K
Other events
Sep 18, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Delisting notice or listing-rule failure
Jul 26, 2024
8-K
Delisting notice or listing-rule failure
May 24, 2024
8-K
Regulation FD disclosure
May 22, 2024
10-Q
Quarter ended 2024-03-31
May 15, 2024